Apollo Hospitals

    APOLLOHOSP
    Pharma
    ₹8836.00
    price as of 11/9/2026, 5:27:56 pm

    Market cap ₹1.27 L Cr

    P/E
    60.91
    Day range
    ₹8,806.00 – ₹8,950.00
    52-week range
    ₹6,696.50 – ₹9,050.00
    Volume
    2.08 L
    Open
    ₹8,806.00
    Prev close
    ₹8,900.00
    Promoters pledged 4.3% of their shares
    52-week range, adjusted for splits and bonuses
    ₹6,696.5₹9,050
    23 Jan 20264 Aug 2026
    Index membership & F&O
    NIFTY 50NIFTY 100NIFTY 200NIFTY 500NIFTY HEALTHCAREF&O lot 125

    Price history

    6M change +14.99%RSI (14) 51.4 NeutralSMA 20 · 50 overlaid

    Price & delivery on the exchange

    NSE bhavcopy to 11 Sept 2026 · delivery 61.1% today vs 58.8% average · BSE close ₹8,850

    1 Apr23 Apr15 May5 Jun24 Jun15 Jul3 Aug21 Aug11 Sept₹6,500₹7,150₹7,800₹8,450₹9,1000%25%50%75%100%
    • Delivery
    • NSE close
    • BSE close

    High delivery with a rising price suggests buyers holding rather than trading the move.

    Futures & options

    NSE F&O close, 11 Sept 2026 · options expiring 29 Sept 2026

    Long unwinding
    Near-month future
    ₹8,893.5
    Change
    -0.06%
    Basis over spot
    +₹57.46
    Futures OI (shares)
    22.7 L
    OI change
    -0.60%
    Put-call ratio
    0.69
    Max pain
    ₹8,800
    Resistance (call OI)
    ₹9,000
    Support (put OI)
    ₹8,300
    Lot size
    125

    Open interest by strike

    Calls open above (resistance) and puts below (support), in shares

    76007900810083008500870089009100930095009700990010200070,0001.4 L2.1 L2.8 Lspot
    • Call OI
    • Put OI

    Futures open interest and price

    Near-month future, day by day since collection began

    The daily history builds from each close.

    Key metrics

    P/E (TTM)
    59.7
    EPS (TTM)
    ₹145.21
    Price / Book
    13.60
    ROE (FY26)
    22.6%
    ROCE (latest year)
    17%
    Dividend yield
    0.22%
    Net margin (TTM)
    8.1%
    Current ratio
    1.06
    Debt / Equity
    0.54
    Revenue growth (5y)
    19.0%
    EPS growth (5y)
    65.9%

    Moving averages (NSE)

    Simple moving averages of the NSE price, and where the last price sits against each
    5-day10-day20-day50-day100-day300-day
    ₹8,730.7Price above₹8,784.6Price above₹8,761.83Price above₹8,825.96Price above₹8,478.41Price above₹7,886.47Price above

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    +14.9%
    Profit 3Y CAGR
    +33.4%
    Revenue YoY (Jun 2026)
    +20.6%
    Profit YoY (Jun 2026)
    +38.3%
    Operating margin
    16.0%
    Net margin
    8.7%

    Revenue, profit & margin - quarterly

    Bars in ₹ crore (a loss shows red); line is operating margin

    Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Jun 20260 Cr2.0K Cr4.0K Cr6.0K Cr8.0K Cr0%4%8%12%16%
    • Revenue
    • Net profit
    • Operating margin

    Who owns the company

    Shareholding as of Jun 2026

    • FII
    • Promoter
    • DII
    • Public
    • Government

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-4.0K Cr-2.0K Cr0 Cr2.0K Cr4.0K Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY17FY18FY19FY20FY21FY22FY23FY24FY25FY260%6%12%18%24%15%

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); line is debt-to-equity

    Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 20260 Cr2.5K Cr5.0K Cr7.5K Cr10.0K Cr0.0x0.3x0.6x0.9x1.2x
    • Equity
    • Debt
    • Debt / equity

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
    Sales4,8474,8514,9445,0865,5895,5275,5925,8426,3046,4776,6067,044
    Expenses4,2194,2374,3034,4104,7744,7654,8224,9905,3625,5125,5945,951
    Operating Profit6286146406758167627708529419651,0111,092
    OPM %13%13%13%13%15%14%14%15%15%15%15%16%
    Other Income262937494469725461485462
    Interest111113119116118110115108110113119120
    Depreciation163167190177184185211215218219224235
    Profit before tax379363368430557536516583675682722799
    Tax %34%30%30%27%29%29%20%24%27%24%24%24%
    Net Profit249254258316396379414441494516551610
    EPS in Rs₹16.20₹17.06₹17.65₹21.23₹26.34₹25.89₹27.10₹30.10₹33.19₹34.93₹36.81₹40.39

    From company filings, updated 11 Sept 2026. Consolidated figures where the company reports them.Information only, not investment advice.

    Strengths, risks & growth

    Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several Retail Health models. [1]

    Strengths

    • Company has delivered good profit growth of 76.2% CAGR over last 5 years
    • Company has been maintaining a healthy dividend payout of 17.7%

    Risks

    • Stock is trading at 13.4 times its book value
    • Company might be capitalizing the interest cost

    Compounded Sales Growth

    10 Years
    +15%
    5 Years
    +19%
    3 Years
    +15%
    TTM
    +17%

    Compounded Profit Growth

    10 Years
    +23%
    5 Years
    +76%
    3 Years
    +32%
    TTM
    +34%

    Stock Price CAGR

    10 Years
    +21%
    5 Years
    +13%
    3 Years
    +21%
    1 Year
    +12%

    Return on Equity

    10 Years
    +13%
    5 Years
    +17%
    3 Years
    +18%
    Last Year
    +21%

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderSept 2025Dec 2025Mar 2026Jun 2026Change
    Promoter28.02%28.02%28.02%28.02%0.00 pp
    FII44.20%43.54%42.62%41.49%-1.13 pp
    DII21.12%21.50%22.76%23.72%+0.96 pp
    Government0.23%0.23%0.23%0.23%0.00 pp
    Public6.43%6.71%6.39%6.53%+0.14 pp

    Filed with NSE for Jun 2026: promoters 28.02%, public 71.98% · XBRL filing

    Analysts & fund holdings

    87%
    87% recommend buy
    30 analysts cover the stock
    Valuation vs Health Care Providers & Services
    P/E60.9 vs 46.4
    Sector P/B5.84
    Beta0.58

    Who holds the shares, quarter by quarter

    Mutual funds 17.33% (+0.68 pp)
    Mar 25
    Jun 25
    Sept 25
    Dec 25
    Mar 26
    Jun 26
    • Promoters28.0%
    • Foreign institutions41.5%
    • Mutual funds17.3%
    • Insurance4.8%
    • Other domestic institutions1.5%
    • Retail4.3%
    • Others2.5%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    Axis Large Cap Fund0.74%2.95%+0.03 pp
    HDFC Flexi Cap Fund0.61%0.68%+0.09 pp
    Axis Focused Fund0.48%5.20%-0.03 pp
    ICICI Pru Balanced Advantage Fund0.44%0.73%+0.04 pp
    SBI Flexicap Fund0.40%2.17%+0.00 pp

    Scorecard

    Performance
    Avg
    Valuation
    High
    Growth
    Avg
    Profitability
    High
    Entry point
    Good
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Parasram India.

    Corporate actions

    • dividend
      ₹10.00

      Dividend - Rs 10 Per Sh

      14 Aug 2026
      ex-date
    • dividend
      ₹10.00

      Interim Dividend - Rs 10 Per Sh

      16 Feb 2026
      ex-date
    • dividend
      ₹10.00

      Dividend - Rs 10 Per Share

      19 Aug 2025
      ex-date
    • dividend
      ₹9.00

      Interim Dividend - Rs 9 Per Share

      14 Feb 2025
      ex-date
    • dividend
      ₹10.00

      Annual General Meeting/Dividend - Rs 10 Per Share

      16 Aug 2024
      ex-date
    • dividend
      ₹6.00

      Interim Dividend - Rs 6 Per Share

      20 Feb 2024
      ex-date
    • dividend
      ₹9.00

      Annual General Meeting/Dividend - Rs 9 Per Share

      18 Aug 2023
      ex-date
    • dividend
      ₹6.00

      Interim Dividend - Rs 6 Per Share

      24 Feb 2023
      ex-date
    • dividend
      ₹11.75

      Annual General Meeting/Dividend - Rs 11.75 Per Share

      18 Aug 2022
      ex-date
    • dividend
      ₹3.00

      Annual General Meeting/Dividend - Rs 3 Per Share

      18 Aug 2021
      ex-date
    • dividend
      ₹2.75

      Annual General Meeting/Dividend - Rs 2.75 Per Share

      17 Sept 2020
      ex-date
    • dividend
      ₹3.25

      Interim Dividend - Rs 3.25 Per Share

      25 Feb 2020
      ex-date
    • dividend
      ₹6.00

      Annual General Meeting/Dividend - Rs 6 Per Share

      12 Sept 2019
      ex-date
    • dividend
      ₹5.00

      Annual General Meeting/Dividend- Rs 5 Per Share

      12 Sept 2018
      ex-date
    • dividend
      ₹6.00

      Annual General Meeting/Dividend - Rs 6/- Per Share

      7 Sept 2017
      ex-date
    • dividend
      ₹6.00

      Interim Dividend - Rs 6/- Per Share (Purpose Revised)

      22 Mar 2016
      ex-date
    • dividend
      ₹5.75

      Annual General Meeting/Dividend Rs 5.75 Per Share

      30 Jul 2015
      ex-date
    • dividend
      ₹5.75

      Annual General Meeting And Dividend Rs.5.75 Per Share

      13 Aug 2014
      ex-date
    • dividend
      ₹5.50

      Annual General Meeting And Dividend Rs.5.50 Per Share

      25 Jul 2013
      ex-date
    • dividend
      ₹4.00

      Annual General Meeting/Dividend Rs 4 Per Share

      26 Jul 2012
      ex-date
    • dividend
      ₹3.75

      Annual General Meeting And Dividend Rs.3.75 Per Share

      7 Jul 2011
      ex-date

    Insider trades

    Last 12 months, market trades
    No market trades
    1 buys · ₹0
    2 sells · ₹0
    Latest insider trades disclosed to NSE
    PersonTypeSharesValueDisclosed
    KARTHIK ANAND
    Promoters · Inter-se-Transfer
    		Sell1,10,000₹030 Dec 2025
    p vijayakumar reddy
    Promoters · Inter-se-Transfer
    		Buy2,20,000₹030 Dec 2025
    HARSHAD REDDY
    Promoters · Inter-se-Transfer
    		Sell1,10,000₹030 Dec 2025
    SUNEETA REDDY
    Promoters · Revokation of Pledge
    		Pledge released1,50,000₹112 Cr18 Nov 2025
    PCR INVESTMENTS LIMITED
    Promoters · Revokation of Pledge
    		Pledge released23,00,000₹181 Cr17 Oct 2025
    K VISHWESHWAR REDDY
    Promoters · Pledge Creation
    		Pledge70,000₹52.1 Cr30 Sept 2025
    SUNEETA REDDY
    Promoters · Revokation of Pledge
    		Pledge released1,75,000₹138 Cr12 Sept 2025
    K VISHWESHWAR REDDY
    Promoters · Revokation of Pledge
    		Pledge released2,77,946₹220 Cr10 Sept 2025
    SUNEETA REDDY
    Promoters · Revokation of Pledge
    		Pledge released5,75,000₹445 Cr5 Sept 2025
    PCR INVESTMENTS LIMITED
    Promoters · Revokation of Pledge
    		Pledge released12,25,000₹947 Cr30 Aug 2025
    K VISHWESHWAR REDDY
    Promoters · Pledge Creation
    		Pledge1,10,000₹83.7 Cr30 Aug 2025
    SUNEETA REDDY
    Promoters · Market Sale
    		Sell18,97,239₹1483 Cr26 Aug 2025

    Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.

    Bulk & block deals

    Bought 40,265 · sold 92,363 shares
    Large deals reported to NSE in this stock
    DateClientTypeQuantityPrice
    17 Sept 2025GOLDMAN SACHS (SINGAPORE) PTE - ODIBlock sell52,098₹7,852.5
    15 Sept 2025GOLDMAN SACHS (SINGAPORE) PTE - ODIBlock sell40,265₹7,874.5
    15 Sept 2025GOLDMAN SACHS BANK EUROPE SE - ODIBlock buy40,265₹7,874.5

    Deals of more than 0.5% of shares (bulk), large single trades (block) and short sales, as NSE reports them.

    Company announcements

    Company Update
    Notice For Transfer Of Shares To IEPF

    as per annexure enclosed

    Others
    Reg. 34 (1) Annual Report.

    Dear Sir, Sub : Submission of Updated Annual Report for FY 2025-26 We refer to the Annual Report of the Company for the financial year ended 31 March 2026, which was submitted to the ....

    Company Update
    Summary Of Proceedings Of AGM And Voting Results

    As per annexure enclosed

    AGM/EGMPrice-sensitive
    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    As per annexure enclosed

    AGM/EGMPrice-sensitive
    Shareholder Meeting / Postal Ballot-Outcome of AGM

    As per annexure enclosed

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    as per annexure enclosed

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    As per annexure enclosed

    Company Update
    Announcement under Regulation 30 (LODR)-Investor Presentation

    As per annexure enclosed

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    As per annexure enclosed

    Company Update
    Announcement under Regulation 30 (LODR)-Press Release / Media Release

    As per annexure enclosec

    Board Meeting
    Board Meeting Outcome for Outcome Of The Board Meeting

    As per annexure enclosed

    Result
    Outcome Of The Board Meeting - Financial Results

    As per annexure enclosed

    Company Update
    Notice Published In News Papers - 45Th AGM And Evoting Related Information; Record Date For Payment Of Dividend Etc

    as per annexure enclosed

    AGM/EGMPrice-sensitive
    Shareholders Meeting On 25Th August 2026

    As per annexure enclosed

    Others
    Reg. 34 (1) Annual Report.

    As per annexure enclosed

    Filed with BSE (scrip 508869); the last 45 days. Documents open at bseindia.com.

    Documents

    Annual reports

    Earnings calls

    Credit ratings

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 11 Feb 2025 (unaudited). View the source filing. Figures are as filed and are not investment advice.